{
  "retracted": false,
  "timestamp": 1583193600000,
  "updates": [
    {
      "timestamp": 1591758253220,
      "identifier": {
        "doi": "10.1186/s12885-020-6678-x"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s12885-018-4663-4"
  },
  "journal": "BMC Cancer",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)"
}
